ASP Isotopes financials
$2.64+1.35%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.1M | $4.2M | $16.7M | $4.9M | $1.2M | $1.1M | $1.2M | $1.1M | $1.0M | $840.4K | $433.0K | $0.00 |
| Gross profit | $1.5M | $1.7M | $2.1M | $423.2K | $572.0K | $327.0K | $605.1K | $294.0K | $421.0K | $278.9K | $139.0K | $0.00 |
| Gross margin | 28.9% | 39.9% | 12.5% | 8.7% | 47.7% | 29.7% | 50.7% | 27.0% | 41.2% | 33.2% | 32.1% | — |
| Operating income | -$34.2M | -$24.9M | -$25.0M | -$15.0M | -$12.0M | -$8.0M | -$7.6M | -$5.4M | -$7.5M | -$5.8M | -$4.0M | -$3.9M |
| Net income | -$33.6M | -$6.9M | -$78.7M | -$12.9M | -$75.1M | -$8.4M | -$9.2M | -$7.3M | -$11.7M | -$6.9M | -$4.2M | -$4.2M |
| Net margin | −655.6% | −164.5% | −472.5% | −263.3% | −6265.6% | −766.4% | −769.2% | −668.5% | −1145.7% | −826.8% | −961.2% | — |
| Diluted EPS | $-0.27 | $-0.06 | $-0.78 | $-0.15 | $-1.03 | $-0.12 | $-0.14 | $-0.12 | $-0.24 | $-0.16 | $-0.10 | $-0.14 |
| EBITDA | -$33.0M | -$21.8M | -$24.1M | -$14.7M | -$11.4M | -$7.8M | -$7.6M | -$5.3M | -$7.3M | -$5.7M | -$4.0M | -$3.9M |
| Operating cash flow | -$23.3M | -$17.8M | -$17.9M | -$8.9M | -$7.9M | -$3.2M | -$3.8M | -$4.8M | -$5.1M | -$3.0M | -$2.1M | -$653.3K |
| Free cash flow | -$27.4M | -$23.9M | -$20.2M | -$12.0M | -$9.7M | -$5.5M | -$6.8M | -$9.3M | -$7.7M | -$4.2M | -$3.2M | -$1.3M |
| Diluted shares | 122.7M | 121.0M | 101.0M | 88.6M | 73.0M | 69.5M | 67.5M | 61.5M | 49.1M | 44.6M | 42.2M | 31.1M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $219.6M | $207.3M | $279.6M | $113.9M | $67.7M | $56.0M |
| Short-term investments | $35.3M | $83.2M | $47.7M | $0.00 | $0.00 | $0.00 |
| Total debt | $263.7M | $258.8M | $202.0M | $112.6M | $100.5M | $37.3M |
| Total assets | $572.0M | $587.7M | $498.0M | $225.9M | $135.9M | $90.9M |
| Total liabilities | $297.3M | $288.7M | $235.1M | $129.3M | $107.6M | $45.1M |
| Shareholders' equity | $274.8M | $299.0M | $262.9M | $96.6M | $28.3M | $45.7M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology